Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Shanghai Fosun Pharmaceutical (Group) Co., Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 1.47% vs -2.69% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 20.97% vs 18.54% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "45,005.90",
          "val2": "44,355.50",
          "chgp": "1.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6,861.80",
          "val2": "6,332.50",
          "chgp": "8.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,372.30",
          "val2": "1,552.50",
          "chgp": "-11.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "13.50",
          "val2": "-39.30",
          "chgp": "134.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,607.00",
          "val2": "3,808.30",
          "chgp": "20.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "62.70%",
          "val2": "65.30%",
          "chgp": "-0.26%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

45,005.90

44,355.50

1.47%

Operating Profit (PBDIT) excl Other Income

6,861.80

6,332.50

8.36%

Interest

1,372.30

1,552.50

-11.61%

Exceptional Items

13.50

-39.30

134.35%

Consolidate Net Profit

4,607.00

3,808.30

20.97%

Operating Profit Margin (Excl OI)

62.70%

65.30%

-0.26%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 1.47% vs -2.69% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 20.97% vs 18.54% in Dec 2024

All Annual Results